Anpario plc (FRA:KI9A)

Market Cap	111.73M
Revenue (ttm)	46.19M
Net Income (ttm)	4.97M
Shares Out	n/a
EPS (ttm)	0.30
PE Ratio	22.47
Forward PE	n/a
Dividend	0.13 (2.51%)
Ex-Dividend Date	Jul 10, 2025

Volume	n/a
Average Volume	12
Open	5.20
Previous Close	5.20
Day's Range	5.20 - 5.25
52-Week Range	2.76 - 6.15
Beta	n/a
RSI	70.14
Earnings Date	Jun 11, 2025

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzy...

• Industry: Food and Kindred Products
• Founded: 1996
• Employees: 157
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: KI9A

Financial Performance

In 2024, Anpario's revenue was 38.20 million, an increase of 23.22% compared to the previous year's 31.00 million. Earnings were 4.11 million, an increase of 62.66%.

Financial numbers in GBP